0.27. Insider Trading. Peter Kies is the chief financial officer at Inovio Pharmaceuticals, a role he has held since 2002. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in … INO stock is trading at a margin of -4.31%, -18.24% and -33.03% apart from the 20-Day, 50-Day and 200-Day Simple Moving Average prices. Insider Trading - KIES PETER Select Time period: 1 Month 2 Months 3 Months 6 Months 1 Year 2 Years 3 Years 4 Years 5 Years 6 Years 7 Years 8 Years 9 Years 10 Years 11 Years 12 Years 13 Years 14 Years 15 Years 16 Years 17 Years 18 Years 19 Years 20 Years All Data Director. Insider Trading Reports are indicating that there were more than several insider trading activities at INO starting from KIES PETER, who sale 10,000 shares at the price of $8.52 back on Apr 21. The stock is trading -74.46 percent below its 52-week high and … Inovio Pharmaceuticals has a market cap of $594.0 million and is part of the health care sector and drugs industry. $173,038. Find real-time INO - Inovio Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. The IRREFUTABLE LAWS of the MARKET. For more information, visit www.inovio.com . 23 March, 2021. Inovio Pharmaceuticals Inc. [NASDAQ: INO] closed the trading session at $7.04 on 05/25/21. The following positions have been held: Officer; Chief Scientific Officer 2020 at INOVIO PHARMACEUTICALS, INC. The 2020 congressional insider trading scandal was a political scandal in the United States involving allegations that several members of the United States Senate violated the STOCK Act by selling stock at the start of COVID-19 pandemic in the United States and just before a stock market crash on February 20, 2020, using knowledge given to them at a closed Senate meeting. Luckily, our subscribers and readers had us assess the situation and we said to ignore Citron and Andrew Left. Real-time Insider Trading Stock Screener. INO is in the manufacturing sector and the measuring, analyzing, and controlling instruments; photographic, medical and optical goods; watches and clocks industry. Inovio Pharmaceuticals (NASDAQ:INO) engages in the discovery and development of synthetic vaccines and immune therapies focusing on cancers and infectious diseases. Get the hottest stocks to trade every day before the market opens 100% free. Top Gainers and Losers. Its product pipeline include VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. Options Trading; Practice Simulator ... Keywords. Inovio Pharmaceuticals. Long and Short Trading Ideas using Insider Transaction Data. Insider Trading Reports are indicating that there were more than several insider trading activities at INO starting from KIES PETER, who sale 10,000 shares at the price of $8.52 back on Apr 21. Summary. Insider buying by insider … The attached Insider Trading Policy provides guidelines to all Company personnel as to transactions in the Company’s securities Every PR will increase INO short ratio relative to outstanding, this may go on for some time while shorts try to strategize an exit, the exit options should be swift and immediate if not the losses will be catastrophic beyond potentially what has ever been recorded in a single day/s/week of trading. Search by keyword... googlecse WANT TO CATCH INO NEWS BEFORE IT CHANGES THE STOCK PRICE? Selection Criteria. NasdaqGS:INO Insider Trading January 23rd 19 If you are like me, then you will not want to miss this free list of growing companies that insiders are buying. Off-Exchange Trading. ... What Did We Find About Insider Trading At Syros Pharmaceuticals, Inc. (NASDAQ:SYRS)? Insider Trading - Kim Jong Joseph Select Time period: 1 Month 2 Months 3 Months 6 Months 1 Year 2 Years 3 Years 4 Years 5 Years 6 Years 7 Years 8 Years 9 Years 10 Years 11 Years 12 Years 13 Years 14 Years 15 Years 16 Years 17 Years 18 Years 19 Years 20 Years All Data Edit Profile. Hedge Fund and Insider Trading News: David Einhorn, Bill Ackman, Warren Buffett... Inovio Pharmaceuticals is COVID-19’s Theranos: Citron Monthly Newsletter Strategy Find the latest Insider Activity data for Inovio Pharmaceuticals, Inc. Common Stock (INO) at Nasdaq.com. Sectors. Executive Summary. Inovio shares surged 13% on the news in a deeply negative market. Timeframe : Day Week Month 3 Months 6 Months 1 Year 2 Years ... INOVIO PHARMACEUTICALS Inc : BENITO SIMON X: Director : 20 May 2020: Sale : 8,750: 15.9536: 139,594: D 5 'Strong Buy' Stocks for the Final Quarter. Humeau Laurent has traded INO while serving in roles requiring financial disclosures. Inovio Pharma Insider Trading Activities Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Evidence of COVID-19 insider trading can fuel more than government investigations and enforcement actions. [ May 11, 2021 ] Ginkgo Bioworks IPO: Biotech Bringing Stock via $15 Billion SPAC Deal Trading Ideas [ May 11, 2021 ] Novavax, Inovio Stocks Hammered As Covid Vaccine News Disappoints Trading Ideas [ May 11, 2021 ] What Does Investing Mean? Inovio Pharmaceuticals, Inc. (NASDAQ:INO) traded at $7.16 at close of the session on Monday, May 24, made an upward move of 1.42% on its previous day’s price. For the readers interested in the stock health of Inovio Pharmaceuticals Inc. (INO). SEC.report › Insider Transaction Feed › Humeau Laurent › Insider Trading. Long and Short Trading Ideas using Insider Transaction Data. INOVIO PHARMACEUTICALS, INC. : News, information and stories for INOVIO PHARMACEUTICALS, INC. | Nasdaq: INO | Nasdaq Inovio Pharmaceuticals, Inc. INO Stock Message Board: https://www.secform4.com/insider-trading/1055726.htm Just a sampling of Form 4 Insider sales https://www.secform4.com/insider-trading/1055726.htm Inovio Pharmaceuticals, Inc. INO Stock Message Board: Little insider selling on the 29th. The company, which spun out of the University of Pennsylvania Medical School and was known as VGX Pharmaceuticals until 2009, currently has around 300 employees and a market cap of $500 million. Stock Charts. Realtime insider trades involving Inovio Pharmaceuticals, Inc.. Security Date/Time Rebate Rate Fee Rate Shares Available; INOVIO PHARMACEUTICALS INC INO: 2021-05-14 22:15:03 UTC-9.6863: 9.7363: 100000: INOVIO PHARMACEUTICALS INC INO Free, legal insider trading data for YARNO WENDY L, a Director of INOVIO PHARMACEUTICALS INC (INO) Inovio Pharmaceuticals (INO) has been playing catch up in the Covid-19 vaccine race for a while now. SIX STEPS that every trader needs to know to succeed in the markets.. DATAROMA Dataroma Value Investing Reset. This event was filed by Inovio Pharmaceuticals In with SEC on 2020-03-09. The performance of the investment from the time Inovio Pharmaceuticals insider buying occurred is the ultimate test of whether insiders were right about INO being a good buy. INO - Buyers volume is there on the break out of today's chart, it is expected to go up from the current levels only if sustains above 9.75 Maintain stop loss around 9.1 Potential upside target 10.25 If sustains below 9.75 go short with the stop loss around 9.85 with the target of 9.35. After this action, KIES PETER now owns 160,788 shares of Inovio Pharmaceuticals Inc., valued at $85,200 using the latest closing price. This information will move a market up or down depending on the insiders' information. Insider Trading and Section 10(b) Securities Class Actions. Inovio Pharmaceuticals Inc (INO stock) was on its way to the moon early last month until noted market manipulator Andrew Left came out with his hit piece on the stock. CEO of Inovio Pharmaceuticals Inc (30-Year Financial, Insider Trades) Jong Joseph Kim (insider trades) sold 162,500 shares of INO on 02/03/2021 at an average price of $14.71 a share. Back to INO Overview Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). INO insider trading. Putting the legal and trading case arguments against the remarks sent out by Citron Research Analyst, March 9, 2020, then threatened, used High-Frequency Trading with short-selling actions immediately the same day to drive down share value of Inovio Pharmaceutical INO.. How different was the announcement by GlaxoSmithKline, GSX, and Sanofi-Aventis S.A., SNY their … Analyzer. Currently, Inovio Pharmaceuticals has an average volume of 722.1K. Insider Trading. "When we look at the immune response that you can induce with a modest dose - one that's feasible to be translated into humans - and the amount of time it takes to get to that level of immunity, it is really quite impressive," Fauci was quoted as saying when discussing both Moderna's vaccine candidate and the one being developed at Oxford. Insider Trading Report. In general, it is generally illegal for insiders to make trades in their companies based on material, non-public information. After this action, KIES PETER now owns 160,788 shares of Inovio Pharmaceuticals Inc., valued at $85,200 using the latest closing price. Inovio Pharmaceuticals (NASDAQ:INO) Insider Buying and Selling Activity … Track real time insider trade and transaction information. The day’s price range saw the stock hit a low of $6.995, while the highest price level was $7.29. A hold rating indicates that analysts believe investors should maintain any existing positions they have in INO, but not buy additional shares or sell existing shares. View analyst ratings for Inovio Pharmaceuticals or view top-rated stocks. One of the early frontrunners, the biotech has been unable to get its DNA Covid-19 vaccine INO-4800 to Phase 3 testing yet. When the transactions were called off in the previous session, Stock hit the highs of $7.27, after setting-off with the price of $7.0576. Find the latest Insider Activity data for Inovio Pharmaceuticals, Inc. Common Stock (INO) at Nasdaq.com. This page shows the track record and history of Weiner David B. insider trades in Inovio Pharmaceuticals Inc. Inovio Pharmaceuticals, Inc. Blog on Talkmarkets | Page 1. Inovio Pharmaceuticals' stock was trading at $8.37 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, INO stock has decreased by 5.7% and is now trading at $7.89. View which stocks have been most impacted by Coronavirus. Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Step 1: A move begins with the sponsors (smart traders) who have insider knowledge as it relates to a particular stock or market. Below we present the annualized performance delivered by Inovio Pharmaceuticals stock since 6-5-2019 (the date of the most recent insider purchase). Prior to Inovio, he spent 16 years acquiring experience in functional and strategic management for biotech and high-tech companies spanning the spectrum … Find the best performing Analyst in each sector. Real-time Insider Trading Stock Screener. Company’s stock value dipped to $6.83 duri Yesterday's off-exchange activity. Company profile for Inovio Pharmaceuticals Inc. including key executives, insider trading, ownership, revenue and average growth rates. View detailed INO description & address. Plus, we'll alert you to all the hot penny stock picks, dividend stocks, micro-caps, small-cap insider trading and global small-cap stocks. Stock Market. Capital Expenditure. login register. Statement of changes in beneficial ownership - SEC Form 4 Cash Floor Correlation. Analysts are bullish on the stock, which ended last week's trading at $43 per share, so the above purchase seems well-timed.The share price is up more than 95% since Peloton's year-to … https://www.secform4.com/insider-trading/1055726.htm Most Active. We know you'll enjoy it! Short Sales. Powering a New Decade of DNA Medicines. Inovio… Inovio is a pharmaceutical company that develops treatments for cancer and other chronic infectious diseases. The company report on May 25, 2021 that INOVIO to Present at … The trades are so quick, often before the information is widely disseminated, that authorities are debating whether they violate insider trading rules, the people familiar with the matter said. INOVIO’s first-of-their-kind DNA medicines are precisely designed DNA plasmids delivered through INOVIO’s proprietary smart device — CELLECTRA ® — directly into the body’s cells to produce an immune response robust enough to potentially treat or prevent disease.. How INOVIO’s DNA Medicines Work: MOA Insiders include: Shea Jacqueline Elizabeth Officer; Chief Operating Officer 2021; Shepard Jay Director; 2021; KIES PETER Officer; CFO 2021; Zoth Lota S. Director; 2021 BENITO SIMON X Director; 2021; Kim Jong Joseph Director; Officer; Chief Executive Officer 2020; Weiner David B. Shares are up 7.63% year-to-date as of the close of trading on Monday. The number of shares owned by shareholders was adjusted after the market closes on Thursday, June 5th 2014. An investor that had 100 shares of Inovio Pharmaceuticals stock prior to the reverse split would have 25 shares after the split. What price target have analysts set for INO? Click here … Hedge Fund Whale Backtesting and search tools The Dow Jones Industrial Average DJIA, +0.36% was recently down more than 2,000 points, or 9%, while the S&P 500 SPX, … Its product pipeline include VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. As of the close of trading, INO deals in the Healthcare domain. It is currently valued at $7.16. INO: Inovio Pharmaceuticals, Inc. - Insider Transactions Get the latest Insider Transactions for Inovio Pharmaceuticals, Inc. from Zacks Investment Research Off-Exchange Volume. Inovio Pharmaceuticals Inc insider trades are shown in the following chart. All metrics are calculated based on the last six months of trading activity by a company's directors and management. Based on 4 analyst ratings, the analyst consensus is Strong Buy with an average price target of $10.25, reflecting a 91.6% upside. Inovio Pharmaceuticals, Inc. INO Stock Message Board: Little insider selling on the 29th. Inovio’s (INO) INO-4800 can be a Valuable Vaccine Arsenal Upon FDA Approval Wasatch Advisors, an employee-owned investment manager, published its ‘Wasatch Micro Cap Value Fund’ third … New 52 Week High and Low. Researching Inovio Pharmaceuticals (NASDAQ:INO) stock? Insider Trading: Relationship: Date: Transaction: Cost: #Shares: Value ($) #Shares Total: SEC Form 4: Weiner David B. Check Form 4 filings and Form 3/5 reporting. View INO's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. Insider trades for Inovio Pharmaceuticals, Inc. (INO). Stocks with insider trader activity include INO, MSI and IDI Yesterday, Sept. 30, 2015, 42 U.S. common stocks issued filings of shares being bought or … It also can help private class action plaintiffs support a case for corporate liability under Section 10(b) of the Securities Exchange Act of 1934. These buyers are smart, very smart, and recognize trading… 636,898. INOVIO also is a proud recipient of 2020 Women on Boards "W" designation recognizing companies with more than 20% women on their board of directors. I have been tracking Inovio Pharmaceuticals insider trading activity, unlike Moderna, C-level executives are holding a substantial amount of shares. Kim Jong Joseph The estimated Net Worth of Kim Jong Joseph is at least $14 Million dollars dollars as of 05/17/2021. Insider Trading Policy of Inovio Pharmaceuticals, Inc., a Delaware corporation (the “Company”) attached hereto as Exhibit B and incorporated herein by reference. Security Date/Time Rebate Rate Fee Rate Shares Available; INOVIO PHARMACEUTICALS INC INO: 2021-05-14 22:15:03 UTC-9.6863: 9.7363: 100000: INOVIO PHARMACEUTICALS INC INO Technical and Fundamental Analysis Report of Inovio Pharma(NASDAQ:INO) stock. The vaccine combines four different HIV antigens together with Inovio’s INO-9012, which carries the DNA code for immune activator IL-12. ... Get a breakdown of the different strategies based on detected insider trading activity. Monitor SEC Form 4 Insider Trading Filings for Insider Buying and Selling. Director; 2020 DPI. Description: Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases.The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies. Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Files An 8-K Costs Associated with Exit or Disposal ActivitiesItem 2.05 INOVIO PHARMACEUTICALS, INC. ExhibitEX … Business Insider 3/2/2021. He had 35,000 Inovio options to buy INO stock at $2.40 a share vest in February 2012. The insider sentiment on Inovio Pharmaceuticals has been negative according to 22 insider trades in the past three months. [ May 22, 2021 ] What is a Reverse Morris Trust: Yahoo U Trading Ideas [ May 22, 2021 ] ASML, Google Lead 5 Stocks That You Can Buy Now Trading Ideas [ May 22, 2021 ] Biden’s $10 billion in mortgage aid is on the way — here’s how you qualify Trading Ideas Insider Trading activities at Inovio Pharmaceuticals, Inc. (INO) Insider trading activities … Discover why corporate insiders sold shares worth in the last 3 months. Inovio Pharmaceuticals (NASDAQ:INO) Insider Trades . Sign up to Insider Financial today! Inovio Pharmaceuticals, Inc. (Inovio) is a late-stage biotechnology company, which is involved in developing deoxyribonucleic acid (DNA) immunotherapies and vaccines focused on treating and preventing cancers and infectious diseases. Kim Jong Joseph is the CEO of Inovio Pharmaceuticals Inc. Kim Jong Joseph owns over 2,001,686 shares of Inovio Pharmaceuticals Inc stock worth over $14 Million dollars . Inovio Has Bigger Value Drivers Outside Of COVID-19 Vaccine Program: BofA Analyst. Stock Screener. However, Oppenheimer’s Hartaj Singh thinks the latest update should change all that. Homepage - Tools. Thank you, we have already received your request for this free offer and it is being processed. Humeau Laurent - SEC Form 4 Insider Trading Screener CIK: 1770390 - Address: C/o Inovio Pharmaceuticals, Inc., 6769 Mesa Ridge Rd., San Diego, CA 92121 General Get the latest OTC Markets stock news and headlines to help you in your trading and investing decisions. 93% of patients showed a … Insider … ... 359K shares were sold in insider trading. In response to the widespread outbreak of the COVID-19 pandemic in the United States, the U.S. Securities and Exchange Commission (SEC) has granted some flexibility to issuers with respect to their obligations to file p eriodic reports and deliver proxy and information statements to shareholders under the Securities Exchange Act. Insiders are officers, directors, or significant investors in a company. WhaleWisdom tracks 13F, Schedule 13D, and 13G EDGAR filings by hedge funds. Inovio Pharmaceuticals, Inc. (NASDAQ:INO) released its quarterly earnings results on Monday, November, 9th. The biopharmaceutical company reported $0.11 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of ($0.19) by $0.30. Insider trading at INO; Latest 13D filings for all companies; SC 13G/A view 2021-02-10: VANGUARD GROUP INC CIK: 102909. Business Address: PO BOX 2600 V26 VALLEY FORGE PA 19482-2600 6106691000. INO stock dropped from $19 to $5 on the news and Left made a killing on his shorts. 2,357,558. Free, legal insider trading data for (INO), a $1,305 million market cap firm trading for $6.23 on the NASD exchange (5/13/21). Get the most recent insider transactions for Inovio Pharmaceuticals Inc (INO). Monitor SEC Form 4 Insider Trading Filings for Insider Buying and Selling. Insider Trading Watch in Green Mountain Coffee Roasters, FedEx, American Tower, Family Dollar Stores, Fifth Third Bancorp, and Inovio Pharmaceuticals News provided by … Gap Up and Gap Down. INO. INO Insider Trading - INOVIO PHARMACEUTICALS Inc - Form 4 SEC Filings Insider Trading - INOVIO PHARMACEUTICALS Inc (INO) "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" Check whether executives and directors are buying or selling the stock The company, currently valued at $1.47 Billion, closed the recent trade at $7.09 per share which meant it … Track Inovio Pharmaceuticals insider transactions based on SEC Form4. BofA Securities raised the price target for the Inovio Pharmaceuticals Inc. (NASDAQ:INO) stock to “a Neutral”. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA. VALUATION The stock was upgraded by ROTH Capital, who disclosed in a research note on November 10, 2020, from Sell to Neutral and set the price Inovio Pharmaceuticals, Inc. [CIK #1055726] is traded under the the stock symbol: INO. The rating was released on March 23, 2021. Follow them so you never miss a recommendation. Inovio insider trading alert for exercise of restricted stock unit by Peter Kies, CFO, on 3rd of August 2020. Inovio Pharmaceuticals, Inc. (NASDAQ:INO) has a beta value of 0.65 and has seen 3,430,277 shares traded in the recent trading session.
Thorin Oakenshield Dwarf Language, Henry Danger Season 4 Episode, Holmes Light Bulb Changer With Telescoping Pole, Arduino Buzzer Songs All Star, January 2014 Snow Storm, Art Competitions For Students 2020, United Kingdom Police System History, Effects Of Nuclear Testing On The Environment, Quotes From Anthem About Individualism With Page Numbers, Hardest Spelling Bee Words 2020,